5/17
11:07 am
eq
Equillium, Inc. (NASDAQ: EQ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Neutral
Report
Equillium, Inc. (NASDAQ: EQ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
5/14
08:15 am
eq
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease [Yahoo! Finance]
Neutral
Report
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease [Yahoo! Finance]
5/14
08:00 am
eq
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
Neutral
Report
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
5/9
07:44 pm
eq
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/9
04:35 pm
eq
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights [Yahoo! Finance]
High
Report
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights [Yahoo! Finance]
5/9
04:01 pm
eq
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
High
Report
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
5/7
08:25 am
eq
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists [Yahoo! Finance]
Low
Report
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists [Yahoo! Finance]
5/7
08:00 am
eq
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
Low
Report
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
5/9/2024
04:01 pm
EQ
equillium, inc.
BEAT
Report
-15.0%
equillium, inc.
3/25/2024
04:01 pm
EQ
equillium, inc.
BEAT
Report
-16.9%
equillium, inc.
11/8/2023
04:01 pm
EQ
equillium, inc.
BEAT
Report
-4.7%
equillium, inc.
5/9
04:12 pm
eq
Form 10-Q Equillium, Inc. For: Mar 31
High
Report
Form 10-Q Equillium, Inc. For: Mar 31
5/9
04:07 pm
eq
Form 8-K Equillium, Inc. For: May 09
High
Report
Form 8-K Equillium, Inc. For: May 09
4/11
04:10 pm
eq
Form ARS Equillium, Inc. For: Dec 31
Medium
Report
Form ARS Equillium, Inc. For: Dec 31
4/11
04:08 pm
eq
Form DEFA14A Equillium, Inc.
Medium
Report
Form DEFA14A Equillium, Inc.
4/11
04:07 pm
eq
Form DEF 14A Equillium, Inc. For: May 22
Medium
Report
Form DEF 14A Equillium, Inc. For: May 22
4/1
05:07 pm
eq
Form PRE 14A Equillium, Inc. For: May 22
Medium
Report
Form PRE 14A Equillium, Inc. For: May 22
4/1
08:06 am
eq
Form 8-K Equillium, Inc. For: Apr 01
High
Report
Form 8-K Equillium, Inc. For: Apr 01
3/25
04:27 pm
eq
Form S-8 Equillium, Inc.
High
Report
Form S-8 Equillium, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register